| Dr Merse E Turnquest, MD | |
|
225 E 7th St, Apopka, FL 32703-5327 | |
| (407) 905-8827 | |
| (407) 886-4282 |
| Full Name | Dr Merse E Turnquest |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 225 E 7th St, Apopka, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033379094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | ME129492 (Florida) | Primary |
| Entity Name | Central Florida Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467449660 PECOS PAC ID: 0143127951 Enrollment ID: O20031218000228 |
News Archive
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
› Verified 2 days ago
| Entity Name | Community Health Centers, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134258684 PECOS PAC ID: 4082515390 Enrollment ID: O20040120000172 |
News Archive
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
› Verified 2 days ago
| Entity Name | Womens Care Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013902923 PECOS PAC ID: 9234031444 Enrollment ID: O20040127000078 |
News Archive
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
› Verified 2 days ago
| Entity Name | Womens' Health Hospitalists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205295599 PECOS PAC ID: 1850674870 Enrollment ID: O20170216001354 |
News Archive
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Merse E Turnquest, MD 110 S Woodland St, Winter Garden, FL 34787-3546 Ph: (407) 905-8998 | Dr Merse E Turnquest, MD 225 E 7th St, Apopka, FL 32703-5327 Ph: (407) 905-8827 |
News Archive
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
› Verified 2 days ago
Ying Lei, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 225 E 7th St, Apopka, FL 32703 Phone: 407-905-8827 Fax: 407-886-1229 | |
Dr. Sobiah Mallick, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 225 E 7th St, Apopka, FL 32703 Phone: 407-905-8827 Fax: 407-886-4282 | |
Mr. Richard A. Real, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 225 E 7th St, Apopka, FL 32703 Phone: 407-905-8827 Fax: 407-886-4282 | |
Dr. Thomas P Enyart, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1578 W Orange Blossom Trl Bldg 1560, Apopka, FL 32712 Phone: 407-635-3240 Fax: 407-636-7847 | |
Shiela A Bahn, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 225 E 7th St, Apopka, FL 32703 Phone: 407-905-8827 Fax: 407-886-1229 | |
Lawrence Arnold Decker, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 225 E 7th St, Apopka, FL 32703 Phone: 407-886-6201 Fax: 407-814-1229 |